Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study

被引:0
|
作者
Ng, Wern Lynn [1 ]
Bock, Allison M. [2 ]
Kovalenko, Iuliia [1 ]
Wert, Yijin [1 ]
Ng, Lay She [3 ]
Wang, Yucai [4 ]
Nowakowski, Grzegorz S. [4 ]
机构
[1] UPMC Harrisburg, Harrisburg, PA USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Royal Coll Surg Ireland & Univ Coll Dublin Malays, George Town, Malaysia
[4] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA
关键词
D O I
10.1182/blood-2022-171148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3829 / 3830
页数:2
相关论文
共 50 条
  • [31] Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
    Klanova, Magdalena
    Oestergaard, Mikkel Z.
    Trneny, Marek
    Hiddemann, Wolfgang
    Marcus, Robert
    Sehn, Laurie H.
    Vitolo, Umberto
    Bazeos, Alexandra
    Goede, Valentin
    Zeuner, Harald
    Knapp, Andrea
    Sahin, Deniz
    Spielewoy, Nathalie
    Bolen, Christopher R.
    Cardona, Andres
    Klein, Christian
    Venstrom, Jeffrey M.
    Nielsen, Tina
    Fingerle-Rowson, Guenter
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4634 - 4643
  • [32] R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma
    Zhao, Fengyi
    Qin, Yan
    Yang, Jianliang
    Liu, Peng
    He, Xiaohui
    Zhou, Liqiang
    Zhou, Shengyu
    Gui, Lin
    Zhang, Haizeng
    Wang, Xin
    Jiang, Shiyu
    Zhong, Qiaofeng
    Zhou, Yu
    Shi, Yuankai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (06) : 385 - 391
  • [33] DIFFERENT IMMUNOCHEMOTHERAPY REGIMENS FOR PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: A RETROSPECTIVE STUDY ON 86 PREVIOUSLY UNTREATED PATIENTS
    Ilyasova, I.
    Kichigina, M.
    Medvedovskaya, E.
    Trofimova, O.
    Osmanov, E.
    Tumyan, G.
    Falaleeva, N.
    Zeynalova, P.
    HAEMATOLOGICA, 2016, 101 : 698 - 698
  • [34] Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma
    Lamure, Sylvain
    Carles, Camille
    Aquereburu, Quam
    Quittet, Philippe
    Tchernonog, Emmanuelle
    Paul, Franciane
    Jourdan, Eric
    Waultier, Agathe
    Defez, Christine
    Belhadj, Ihssen
    Sanhes, Laurence
    Burcheri, Sara
    Donadio, Daniel
    Exbrayat, Carole
    Saad, Alain
    Labourey, Jean-Luc
    Baldi, Isabelle
    Cartron, Guillaume
    Fabbro-Peray, Pascale
    JAMA NETWORK OPEN, 2019, 2 (04)
  • [35] A retrospective cohort study of polatuzumab vedotin combined with immunochemotherapy in Chinese patients with relapse/refractory diffuse large B cell lymphoma
    Liu, Yanyan
    Wuxiao, Zhijun
    Kong, Fancong
    Feng, Jifeng
    Wu, Jianqiu
    Yao, Zhihua
    Zhou, Weilun
    Li, Fei
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (19)
  • [36] CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference?
    Popovic, L.
    Markovic, O.
    Jovanovic, D.
    Marisavljevic, D.
    Petrovic, D.
    Mihaljevic, B.
    Popovic, M.
    Matkovic, T.
    Matovina-Brko, G.
    Zivkovic, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S845 - S846
  • [37] Cutaneous relapses location in diffuse large B-cell lymphoma leg type after first line immunochemotherapy
    Benarfa, A.
    Ingen-Housz-Oro, S.
    Durot, E.
    Beylot-Barry, M.
    Pham-Ledard, A.
    EUROPEAN JOURNAL OF CANCER, 2025, 214
  • [38] Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy
    Hong, Junshik
    Woo, Hyun Seon
    Kim, Hyunchul
    Ahn, Hee Kyung
    Sym, Sun Jin
    Park, Jinny
    Ahn, Jeong Yeal
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    CANCER SCIENCE, 2014, 105 (12): : 1569 - 1575
  • [39] Risk Factors for Early Death after Immunochemotherapy in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Mantripragada, Kalyan
    Castillo, Jorge J.
    Olszewski, Adam J.
    BLOOD, 2015, 126 (23)
  • [40] Downregulation of autophagy is associated with poor clinical outcome after immunochemotherapy in patients with diffuse large B-cell lymphoma
    Zhang, Ya-Li
    Ma, Meng-Xue
    Xing, Li-Na
    Zhang, Jing-Nan
    Guo, Xiao-Nan
    Qiao, Shu-kai
    EXPERIMENTAL HEMATOLOGY, 2024, 139